Choate represented Transformation Capital in the transaction, while Cuatrecasas represented Vesalius Biocapital III Partners. SWORD Health closed a $25M Series B financing, in which Transformation Capital acted...
Choate represented Transformation Capital in the transaction, while Cuatrecasas represented Vesalius Biocapital III Partners. SWORD Health closed a $25M Series B financing, in which Transformation Capital acted...
You must be a Standard 1 Year member to access this content.